Tested on people, not meters.
Blushield doesn't block or reduce wireless signals, so an EMF meter can't show whether it works. The only way to test it is to measure how people respond. That's what the research below does.
Blushield is one of very few EMF devices to be tested in a published, peer-reviewed human study. Here's the evidence, from the first observations to the clinical research.
The peer-reviewed pilot study
25 adults. 12 weeks. Real homes. Published and indexed on PubMed.
In a 2024 pilot study published in Integrative Medicine, 25 healthy adults used Blushield at home for 12 weeks while carrying on with their phones, Wi-Fi and everyday technology. Researchers tracked their heart rate variability, sleep, cognitive function, blood markers, DNA methylation and self-reported health.
They reported statistically significant improvements in:
- heart rate variability
- deep sleep
- cognitive function (memory, flexibility and processing)
- blood glucose
- methylation of CACNA1G, a gene linked to how cells respond to EMF
- self-reported health
No device-related adverse events were reported.
Read the full study breakdown →
Live blood cell analysis
What blood looks like under the microscope, before and after Blushield.
In 2012, a man in his mid-thirties with high daily EMF exposure had his blood examined under a microscope before using Blushield, and again about 2 months later. The tester recorded more regular red blood cells, stronger cell membranes and less crystallisation in the second sample.
This is an early, observational case study of one person. It isn't peer-reviewed, and live blood analysis isn't a recognised diagnostic test in mainstream medicine. It's a visual record of what one practitioner observed, and it's part of the story of how Blushield's research began.
See the before and after images →
How the evidence fits together
Research builds in stages. Blushield's evidence sits at the first two:
| Stage | What it is | Blushield |
|---|---|---|
| 1. Observation | Early case studies that raise questions worth testing | Live blood cell analysis (2012) |
| 2. Pilot study | A peer-reviewed study to look for measurable effects | D'Adamo et al (2024) |
| 3. Controlled trial | A larger, randomised, placebo-controlled study | The next step |
The live blood analysis showed changes worth investigating. The pilot study then measured objective markers, with an ethics-approved, registered and peer-reviewed design, and found significant changes.
Why Blushield is tested this way
Most EMF products are never tested on people at all. Stickers, pendants and shields are sold on the strength of meter readings or no evidence at all. Blushield's approach is to measure the thing that matters: how the body responds.
The wider research on EMF
Blushield's research sits inside a much larger body of science on how wireless radiation affects the body. That includes a 2025 WHO-commissioned review that found high-certainty evidence of cancer in animals exposed to RF radiation.